• 803 Citations
  • 6 h-Index
20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 803 Citations
  • 6 h-Index
  • 10 Article
  • 2 Review article
2020

Determination of metformin bio-distribution by LC-MS/MS in mice treated with a clinically relevant paradigm

Chaudhari, K., Wang, J., Xu, Y., Winters, A., Wang, L., Dong, X., Cheng, E. Y., Liu, R. & Yang, S. H., 1 Jan 2020, In : PLoS ONE. 15, 6, p. e0234571

Research output: Contribution to journalArticle

Open Access
2018

Current strategies for brain drug delivery

Dong, X., 1 Jan 2018, In : Theranostics. 8, 6, p. 1481-1493 13 p.

Research output: Contribution to journalReview article

120 Scopus citations
2017

Development and characterization of docetaxel-loaded nanoparticles for docetaxel-resistant castration-resistant prostate cancer

Tanaudommongkon, A., Tanaudommongkon, I., Prathipati, P., Nguyen, J. & Dong, X., 1 Jan 2017, In : Journal of Nanoscience and Nanotechnology. 17, 6, p. 3920-3926 7 p.

Research output: Contribution to journalArticle

Preparation and characterization of novel HDL-mimicking nanoparticles for nerve growth factor encapsulation

Zhu, J. & Dong, X., 22 May 2017, In : Journal of Visualized Experiments. 2017, 123, e55584.

Research output: Contribution to journalArticle

2 Scopus citations
2016

Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles

Pham, K., Li, D., Guo, S., Penzak, S. & Dong, X., 28 Mar 2016, In : Journal of Controlled Release. 226, p. 88-97 10 p.

Research output: Contribution to journalArticle

6 Scopus citations
5 Scopus citations
6 Scopus citations
2010

Nanomedicinal strategies to treat multidrug-resistant tumors: Current progress

Dong, X. & Mumper, R. J., 1 Jun 2010, In : Nanomedicine. 5, 4, p. 597-615 19 p.

Research output: Contribution to journalReview article

225 Scopus citations
2009

Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia

Ma, P., Dong, X., Swadley, C. L., Gupte, A., Leggas, M., Ledebur, H. C. & Mumper, R. J., 1 Apr 2009, In : Journal of Biomedical Nanotechnology. 5, 2, p. 151-161 11 p.

Research output: Contribution to journalArticle

126 Scopus citations

Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization

Dong, X., Mattingly, C. A., Tseng, M., Cho, M., Adams, V. R. & Mumper, R. J., 1 May 2009, In : European Journal of Pharmaceutics and Biopharmaceutics. 72, 1, p. 9-17 9 p.

Research output: Contribution to journalArticle

72 Scopus citations

Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP

Dong, X., Mattingly, C. A., Tseng, M. T., Cho, M. J., Liu, Y., Adams, V. R. & Mumper, R. J., 1 May 2009, In : Cancer Research. 69, 9, p. 3918-3926 9 p.

Research output: Contribution to journalArticle

221 Scopus citations
2006

The metabolism of fatty alcohols in lipid nanoparticles by alcohol dehydrogenase

Dong, X. & Mumper, R. J., 1 Sep 2006, In : Drug Development and Industrial Pharmacy. 32, 8, p. 973-980 8 p.

Research output: Contribution to journalArticle

20 Scopus citations